Doxolipad
Country: European Union
Language: Estonian
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
26-08-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
doksorubitsiini vesinikkloriid
Available from:
TLC Biopharmaceuticals B.V.
ATC code:
L01DB01
INN (International Name):
doxorubicin
Therapeutic group:
Antineoplastilised ained
Therapeutic area:
Breast Neoplasms; Ovarian Neoplasms
Therapeutic indications:
Ravi rinna-ja munasarjavähk.
Authorization status:
Keeldutud
